Healthcare Equipment and Supplies
Company Overview of Access Bio, Inc.
Access Bio, Inc. researches, develops, and manufactures in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products. The company’s in vitro diagnostic technology includes immunochemical, biochemical, and molecular products. It serves governments in Europe, the Americas, the South-East Asia, Africa, and the Middle East, as well as non-profit organizations and private companies. The company was founded in 2001 and is headquartered in Somerset, New Jersey with locations in Ethiopia and South Korea.
65 Clyde Road
Somerset, NJ 08873
Founded in 2001
Key Executives for Access Bio, Inc.
Access Bio, Inc. does not have any Key Executives recorded.
Access Bio, Inc. Key Developments
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems, Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
March 15, 2016
December 10, 2015
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Access Bio, Inc., please visit www.accessbio.net. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.